Respinova
Respinova is an Israel-based, privately-held medtech company founded in 2008 that develops treatments for COPD and other respiratory diseases. Operating with 1-10 employees, it has historically been funded by EU grants (EIC and EISMEA) and is currently pre-commercial with no active public-facing presence.
- Company typePrivate
- Founded2008
- HeadquartersHerzliya, Israel
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Respinova firmographics
Firmographics- Name
- Respinova
- Website
- https://respinova.com
- Company type
- Private
- Founded year
- 2008
- Headcount range
- 1–10 employees
- Short description
- Respinova is an Israel-based, privately-held medtech company founded in 2008 that develops treatments for COPD and other respiratory diseases. Operating with 1-10 employees, it has historically been funded by EU grants (EIC and EISMEA) and is currently pre-commercial with no active public-facing presence.
- Ownership category
- akta.pro rank
Respinova industry classification
Industry- Product category
- Respiratory Medical Devices
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- COPD & Chronic Bronchitis Management (HLAKANAE)
- akta.pro secondary industry
- Pulmonary Rehabilitation Programs (HLAKANAL)
Keywords
Where Respinova is headquartered
LocationHeadquarters
- HQ city
- Herzliya
- HQ country
- Israel
- HQ region
- Middle East
Markets served
Respinova business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Respinova product offering
Product offeringCore offering
Respinova develops treatments for Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases. The company focuses on therapeutic solutions targeting pulmonary conditions, operating as a small private medical technology firm based in Herzliya, Israel. Its work centers on novel respiratory interventions for patients suffering from chronic airway and lung diseases.
Differentiator
Problem solved
Functional benefit
Products and services
- COPD Respiratory Treatment A treatment developed by Respinova targeting Chronic Obstructive Pulmonary Disease, intended for use by patients with chronic airway obstruction and related respiratory conditions.
Companies that use Respinova
Customer profileIdeal customer profiles1 record
Respinova technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Respinova competitors and assessment
Company assessmentMarket position
Customer concentration
Respinova social profiles
Digital presenceRespinova financial estimates
Financial estimateRevenue estimate
Valuation estimate
Respinova leadership team
Management profileNumber of profiles
Profiles4 records
Respinova funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Respinova M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Respinova
What does Respinova do?
Respinova develops treatments for Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases. The company focuses on therapeutic solutions targeting pulmonary conditions, operating as a small private medical technology firm based in Herzliya, Israel. Its work centers on novel respiratory interventions for patients suffering from chronic airway and lung diseases.
When was Respinova founded?
Respinova was founded in 2008. It employs 1 to 10 people.
Where is Respinova based?
Respinova is headquartered in Herzliya, Israel, in the Middle East region.
Does Respinova have an API?
No public API is recorded for Respinova.
What industry is Respinova in?
Respinova's product category is Respiratory Medical Devices. Its primary akta.pro industry code is HLAKANAE, COPD & Chronic Bronchitis Management, with a secondary code of HLAKANAL, Pulmonary Rehabilitation Programs. Its NAICS code is 541714 and its SIC code is 8731.